Article

Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring

2026-04-03

Abstract excerpt

<h4>Background: </h4> Pancreatic cancer and ovarian cancer are very challenging to diagnose at early stages. The endoscopic retrieval of biopsy tissue from a suspected benign or malignant lesion is challenging due to the tissue’s nature. Therefore, within the Instand-NGS4P framework, we developed Measurable Residual Disease (MRD) prototypes to analyze blood plasma samples, with the aim of cost-effectively supporti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7b49fa1c-b1f5-5d37-86a2-0f42201ac2e9
DOI: 10.12688/openreseurope.23403.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoringDOI 10.12688/openreseurope.23403.1Read

Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoringSemantic proximity Read

Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study.Semantic proximity Read

Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correctionSemantic proximity Read

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaSemantic proximity Read

Processing UMI Datasets at High Accuracy and Efficiency with the Sentieon ctDNA Analysis PipelineSemantic proximity Read

Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity Read

Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.Semantic proximity Read

Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test.Semantic proximity Read

Error-corrected deep targeted sequencing of circulating cell-free DNA from colorectal cancer patients for sensitive detection of circulating tumor DNASemantic proximity Read

Optimizing Accuracy and Efficiency in Analyzing Non-UMI Liquid Biopsy Datasets Using the Sentieon ctDNA PipelineSemantic proximity Read

Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancerSemantic proximity Read

AI enabled exome and transcriptome liquid biopsy platform spanning the continuum of care in oncologySemantic proximity Read